Citations

Clear

390 citation(s) found for "Loftus, E".

Undetected Dysplasia at Colectomy in Patients With Inflammatory Bowel Diseases. What Are We Missing?
Centorrino, Erica , Harmsen, William S. , Coelho–Prabhu, Nayantara , Coelho-Prabhu, Nayantara , Ferrari, Davide, Larson, David W. , Loftus, Edward V.

Mayo Clinic

Inflammatory Bowel Diseases | November 7, 2024 | Volume: 31 | Issue: 7 | Pages: 1952-1960

10.1093/ibd/izae274 | PMID 39607850 Get It

Abstract Background and Aims Patients with inflammatory bowel disease (IBD) have a higher risk of developing colorectal dysplasia and colorectal cancer compared to the general population. Although the use of surveillance protocols has improved the ability to detect dysplasia, some lesions are still missed at colonoscopy. This study aims to determine the rate of dysplastic lesions that are undetected at colonoscopies in IBD patients undergoing colectomy and to identify factors associated with missed dysplasia. Methods Patients who had received a total or subtotal colectomy at Mayo Clinic (Rochester, Minnesota), between January 2003 and December 2022, and had a complete colonoscopy within 5 years before surgery were retrospectively enrolled. Data abstracted included demographic information, disease-related data, colonoscopy and pathology reports, and surgery pathology reports. Colonoscopy and surgery findings were compared, and patients were divided into 3 groups: no dysplasia at both, detected dysplasia, and undetected dysplasia. Results Among 1320 IBD patients undergoing colectomy, 5.4% had undetected dysplastic lesions identified only at surgery. Factors independently associated with dysplasia detection were endoscopic remission or mild endoscopic disease activity (odds ratio [OR], 2.326; P = .0081; 95% CI, 1.246-4.342), prior dysplasia detection (OR, 1.876; P = .0491; 95% CI, 1.002-3.511), colonoscopy performed for surveillance (OR, 2.380; P = .0048; 95% CI, 1.302-4.350), and longer disease duration at surgery (OR, 1.039; P = .0085; 95% CI, 1.010-1.070). Conclusions Clinicians should be aware of the risk of missing dysplastic lesions, especially when endoscopic disease activity is moderate/severe, and not only for longstanding disease. Efforts should be made to obtain endoscopic remission to make the “invisible” visible.
S1146 Inflammatory Bowel Disease (IBD)-Associated Peripheral Arthritis is Not Associated With Objective Markers of Luminal IBD Disease Activity - Results From the CHASE Cohort
Abushamma, Suha , Barnes, Edward, Bhattacharya, Abhik , Cross, Raymond, Cheemalavagu, Shashank , Colombel, Jean–Frédéric, Horst, Sara N., Hou, Jason K. , Husni, M. Elaine., Scherl, Ellen , Qazi, Taha , Yang, Qijun, Cohen, Benjamin L., Feagan, Brian G., Rieder, Florian , Falloon, Katherine , Ananthakrishnan, Ashwin N. , Gore, Emily , Herfarth, Hans , Horst, Sara , Husni, M. Afif Rijal, Klein, Jeremy A. , Loftus, Edward V. , Lukin, Dana J. , Rubin, David T.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S814-S815

10.14309/01.ajg.0001033952.27750.6a Get It

S1287 Thrombotic Events Among Hospitalized Patients With Inflammatory Bowel Disease, 2016 Through 2020
Bakhshizarrinabadi, Zeinab, Evbayekha, Endurance O , Loftus, Edward V.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S920-S920

10.14309/01.ajg.0001034516.60561.3d Get It

S1050 Efficacy and Safety of Upadacitinib Maintenance Treatment in Patients With Moderately to Severely Active Crohn’s Disease: Two Year Results From the U-ENDURE Long-Term Extension Study
D’Haens, Geert , Louis, Édouard , Regueiro, Miguel, Jairath, Vipul , Dubcenco, Elena, Lacerda, Ana P. , Feng, Tian, Duncan, Benjamin , Anyanwu, Samuel, Aponte, Fernando, Blumenstein, Irina , Jairath, Vipul , Jairath, Vipul , Jairath, V , Jairath, V , Jairath, Vipul , Louis, Edouard , Loftus, Edward V. , Regueiro, Miguel , Magro, Fernando , Nakase, Hiroshi , Feng, Tian, Wang, Tao

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S737-S739

10.14309/01.ajg.0001033568.21496.22 Get It

S899 The Role of Video Quality in Central Reader Disagreement in Assessment of the Endoscopic Mayo Score in Ulcerative Colitis Trials
Reinisch, Walter , Battioui, Chakib , Brinkey, Abbey, Colucci, Daniel , Eastman, William, Thompson, Hannah M. , Baxi, Shrujal S. , Loftus, Edward V. , Rubin, David T. , Coelho–Prabhu, Nayantara , Reinisch, Walter , Wang, Yeli

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S627-S628

10.14309/01.ajg.0001032964.83496.33 Get It

S773 Baseline Severity Correlates with Symptom Improvement on Novel Digital Hypnotherapy Intervention for Bloating
Rajagopal, Anjali , Loftus, Conor G., Ebbert, Jon O. , Wang, Xiao‐Jing , Dilmaghani, Saam , Jin, Mauricio F. , Philpot, Lindsey M. , Palsson, Olafur S.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S533-S534

10.14309/01.ajg.0001032460.90402.c3 Get It

Chlorhexidine Wipes with Educational Feedback Are Effective at Reducing Axilla and Groin Bacterial Contamination at the Start of Surgery
Dexter, Franklin , Loftus, Randy W.

Mayo Clinic

Anesthesia & Analgesia | October 17, 2024 | Volume: 140 | Issue: 5 | Pages: 1233-1235

10.1213/ane.0000000000007288 | PMID 39418200 Get It

Assessment and impact of age on the efficacy and safety among patients in the etrasimod ELEVATE UC clinvical programme
Lichtenstein, Gary, Allegretti, Jessica R. , Irving, Peter M., Charabaty, Aline, Kuehbacher, Tanja, Bananis, Eustratios , Woolcott, John , Dalam, Alexis B, Lazin, K., Keating, Michael J. , McDonnell, A, Allegretti, Jessica R. , Loftus, Edward V. , Banerjee, Rupa , Charabaty, Aline , Lazin, Krisztina , Danese, Silvio

Mayo Clinic

Zeitschrift für Gastroenterologie | October 2, 2024 | Volume: 62 | Issue: 09 | Pages: e605-e606

10.1055/s-0044-1789701 Get It

Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa
Yamanaka‐Takaichi, Mika , Nadalian, Soheila, Loftus, Edward V. , Ehman, Eric C. , Grimaldo, Anna B. , Yalon, Mariana , Matchett, Caroline L. , Patel, Nisha , Isaq, Nasro , Raffals, Laura E., Wetter, David A. , Murphree, Dennis H. , Dozois, Eric J. , Yalon, Mariana , Patel, Nisha B, Isaq, Nasro A., Wetter, D A , Murphree, Dennis H , Tizhoosh, Hamid R , Alavi, A , Loftus, Edward V , Todd, Austin W. , Raffals, Laura E. , Cima, Robert R. , Goldfarb, Noah , Tizhoosh, Hamid R. , Alavi, Afsáneh

Mayo Clinic

International Journal of Dermatology | September 22, 2024 | Volume: 64 | Issue: 3 | Pages: 520-530

10.1111/ijd.17498 | PMID 39306801 Get It

Abstract Background Perianal draining tunnels in hidradenitis suppurativa (HS) and perianal fistulizing inflammatory bowel disease (IBD) present diagnostic and management dilemmas. Methods We conducted a retrospective chart review of patients with perianal disease evaluated at Mayo Clinic from January 1, 1998, through July 31, 2021. Patients' demographic and clinical data were extracted, and 28 clinical features were collected. After experimenting with several machine learning techniques, random forests were used to select the 15 most important clinical features to construct the diagnostic prediction model to distinguish perianal HS from fistulizing perianal IBD. Results A total of 263 patients were included (98 with HS, 100 with IBD, and 65 with both IBD and HS). Patients with HS had a higher mean body mass index, a higher smoking rate, and more commonly showed cutaneous manifestations of tunnels and comedones, while fistulas, abscesses, induration, anal tags, ulcers, and anal fissures were more common in patients with IBD. In addition to having lesions in the perianal area, patients with IBD often had lesions in the buttocks and perineum, while those with HS had additional lesions in the axillae and groin. Among the statistically significant features, the 15 most important were identified by random forest: fistula , tunnel , digestive symptom , knife‐cut ulcer , perineum , body mass index , age , axilla , abscess , tags , smoking , groin , genital cutaneous edema , erythema , and bilateral/unilateral . Conclusions The results of this study may help differentiate perianal lesions, especially perineal HS and fistulizing perineal IBD, and provide promise for a better therapeutic outcome.
Characteristics, clinical outcomes, and prognostic factors of colorectal cancer in patients with Crohn’s disease: American versus Korean tertiary referral center perspectives
Suttichaimongkol, Tanita , Hwang, Sung Wook , Kisiel, John B. , Yang, Suk‐Kyun , Park, Sang Hyoung , Kisiel, John B , Yang, Suk-Kyun , Park, Sang Hyoung , Coelho–Prabhu, Nayantara , Ye, Byong Duk , Loftus, Edward V.

Mayo Clinic

Therapeutic Advances in Gastroenterology | September 18, 2024 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/17562848241275342 | PMID 39314760 Get It

Background:Crohn’s disease (CD) exhibits variability in colorectal cancer (CRC) incidence and prognostic factors due to diverse clinical and behavioral characteristics, presenting inconsistencies between Western and Eastern patients.Objectives:This study compared clinical characteristics between CD patients with CRC from the US and Korean tertiary referral centers and defined the prognostic factors related to mortality.Design:Retrospective study.Methods:We reviewed the electronic medical records of 236 adult CD patients with colorectal adenocarcinoma evaluated at Mayo Clinic Rochester, Florida, or Arizona ( N = 200) and Asan Medical Center in Korea ( N = 36) between January 1989 and August 2022.Results:Asan patients had a younger age, shorter CD duration, more colonic involvement (L2 plus L3), penetrating behavior, perianal fistula, and shorter biological treatment duration before CRC diagnosis than Mayo patients. Furthermore, despite significant differences in body mass index, smoking status, primary sclerosing cholangitis, immunomodulators, CRC diagnosis period, clinical presentation, CRC location, surgery, and some histopathological details between the two groups, overall survival was not statistically different ( p value, 0.29, log-rank test). Advanced age (adjusted hazard ratio (aHR), 1.03 per year; 95% confidence interval (CI), 1.01–1.04; p value, <0.01), unresectable CRC (aHR, 5.02; 95% CI, 2.49–10.12; p value, <0.01), and advanced CRC stage (aHR, 1.45 per stage; 95% CI, 1.07–1.97; p value, 0.02) were significantly associated with increased risk of death. CD remission at CRC diagnosis (aHR, 0.26; 95% CI, 0.08–0.91; p value, 0.04), CRC diagnosis period of 2011–2022 (aHR relative to 1989–2000, 0.46; 95% CI, 0.25–0.87; p value, 0.02), and CRC diagnosis by surveillance (aHR, 0.56; 95% CI, 0.32–0.98; p value, 0.04) were significantly associated with decreased risk of death.Conclusion:Notably, some clinical features of CD with CRC differed between Asan and Mayo patients; however, overall survival was not different. CD remission, CRC surveillance, and more recent diagnosis of CRC were associated with a reduced risk of death.